Recursion Pharmaceuticals Inc Clas (RXRX)
$4.03 -4.95% Close Oct 30, 2026 Live
Recursion Pharmaceuticals Inc Clas stock today
Recursion Pharmaceuticals Inc Clas closed at $4.03 on October 30, 2026, down 4.95% on the day. Over the past year it returned -28.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.14 billion.
$3.00$4.00$5.00
NovJan 2026MarMayJulSep
| Period | RXRX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -2.4% | -0.9% |
| 3 months | +32.6% | +2.1% |
| Year to date | -1.5% | +11.7% |
| 1 year | -28.7% | +12.4% |
| 3 years | -24.1% | +88.5% |
| 5 years | -79.0% | +76.0% |
Key statistics
- Market value
- $2.14B
- Price / sales
- 38.9
- 52-week range
- $2.84 to $5.65
- Next report
- Nov 2, 2026
About Recursion Pharmaceuticals Inc Clas
Recursion Pharmaceuticals uses computational technology and screening to discover drugs for rare and other diseases.
Sector: Health Care
More on Recursion Pharmaceuticals Inc Clas
- Financials: revenue, earnings and segmentsRevenue +27% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $210.44 today
No forecast, no recommendation. This page describes Recursion Pharmaceuticals Inc Clas from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.